A series of studies show the mutational events of PI3K pathway (30.5%) in 151 head and neck squamous cell carcinomas (HNSCCs) containing 29 laryngeal squamous cell carcinomas (LSCCs), particularly PIK3CA mutations of 12.6% [90–92]. The gene discussed is PIK3CB; the disease is head and neck squamous cell carcinoma.